United Therapeutics Corporation (UTHR)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	1,184,900	979,700	555,900	593,600	-187,600
Revenue	US$ in thousands	2,268,200	1,903,900	1,666,900	1,483,300	1,448,800
Operating profit margin		52.24%	51.46%	33.35%	40.02%	-12.95%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $1,184,900K ÷ $2,268,200K
= 52.24%

The operating profit margin for United Therapeutics Corp has shown a positive trend over the past five years, indicating the company's ability to generate profits from its primary business activities. The margin has consistently improved from -12.95% in 2019 to 50.91% in 2023. This demonstrates significant growth and efficiency in managing operating expenses relative to revenue. The substantial increase in operating profit margin suggests that the company has enhanced cost controls, operational efficiency, and revenue generation strategies over the period. Overall, the upward trajectory of the operating profit margin reflects a positive trend in United Therapeutics Corp's profitability and operational performance.